Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer
Abstract Current treatment guidelines refer to small cell lung cancer (SCLC), one of the deadliest human malignancies, as a homogeneous disease. Accordingly, SCLC therapy comprises chemoradiation with or without immunotherapy. Meanwhile, recent studies have made significant advances in subclassifyin...
| Published in: | Molecular Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-02-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12943-024-01953-9 |
